Medtronic Stock Forecast, Price & News

Medtronic (NYSE:MDT) Frequently Asked Questions

Is Medtronic a buy right now?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 5 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic or view top-rated stocks.

What stocks does MarketBeat like better than Medtronic?

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medtronic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Medtronic?

Medtronic saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 8,780,000 shares, a decrease of 17.3% from the August 31st total of 10,620,000 shares. Based on an average daily volume of 3,770,000 shares, the short-interest ratio is presently 2.3 days. Approximately 0.7% of the company's shares are short sold.
View Medtronic's Short Interest.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, November 23rd 2021.
View our earnings forecast for Medtronic.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) released its earnings results on Monday, August, 23rd. The medical technology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.32 by $0.09. The medical technology company earned $7.99 billion during the quarter, compared to the consensus estimate of $7.88 billion. Medtronic had a trailing twelve-month return on equity of 13.85% and a net margin of 12.29%. The business's revenue was up 22.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.62 EPS.
View Medtronic's earnings history.

How has Medtronic's stock been impacted by COVID-19?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDT shares have increased by 34.2% and is now trading at $124.05.
View which stocks have been most impacted by COVID-19.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Monday, August 23rd. Investors of record on Friday, September 24th will be paid a dividend of $0.63 per share on Friday, October 15th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Thursday, September 23rd.
View Medtronic's dividend history.

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 2.04%.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2022 earnings guidance on Tuesday, September, 21st. The company provided EPS guidance of $5.650-$5.750 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.690. The company issued revenue guidance of -.

What price target have analysts set for MDT?

20 brokerages have issued 1-year target prices for Medtronic's shares. Their forecasts range from $119.00 to $165.00. On average, they anticipate Medtronic's stock price to reach $144.20 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price.
View analysts' price targets for Medtronic or view top-rated stocks among Wall Street analysts.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:

• Geoffrey Straub Martha, Chairman & Chief Executive Officer
• Gregory L. Smith, Executive VP-Global Operations & Supply Chain
• Karen L. Parkhill, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Richard E. Kuntz, Chief Medical & Scientific Officer, Senior VP
• Laura Mauri, Chief Clinical & Regulatory Officer, Senior VP

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medtronic's key competitors?

Some companies that are related to Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, Dickinson and (BDX), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Hologic (HOLX), Teleflex (TFX) and Masimo (MASI).
View all of MDT's competitors.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (0.18%), DekaBank Deutsche Girozentrale (0.18%), Coho Partners Ltd. (0.13%), New York State Teachers Retirement System (0.12%), Manning & Napier Group LLC (0.10%) and Strs Ohio (0.08%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic.

Which major investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, New York State Teachers Retirement System, Strs Ohio, Confluence Investment Management LLC, Coho Partners Ltd., Chevy Chase Trust Holdings Inc., National Mutual Insurance Federation of Agricultural Cooperatives, and Andesa Financial Management Inc.. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Carol A Surface, Geoffrey Martha, John R Liddicoat, Karen L Parkhill, Robert John White, and Sean Salmon.
View insider buying and selling activity for Medtronic or view top insider-selling stocks.

Which major investors are buying Medtronic stock?

MDT stock was bought by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, DekaBank Deutsche Girozentrale, Fisher Asset Management LLC, Alpha Cubed Investments LLC, Calamos Advisors LLC, Roberts Wealth Advisors LLC, Sciencast Management LP, and Copeland Capital Management LLC. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $124.05.

How much money does Medtronic make?

Medtronic has a market capitalization of $166.71 billion and generates $30.12 billion in revenue each year.

How many employees does Medtronic have?

Medtronic employs 90,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

Where are Medtronic's headquarters?

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700 or via email at [email protected].